We found that the ability of platelets to aggregate and adhere to cancer cells was also reduced in the presence of clopidogrel, a P2Y12 inhibitor, suggesting that the CysLT1R-dependent pathway of TCIPA potentially requires an autocrine ADP-mediated response through P2Y12 receptors. The gene discussed is CYSLTR1; the disease is cancer.